Clinical trial

Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris

NCT00202566 · Institut de Recherches Internationales Servier, Other · Completed

Key facts

NCT number NCT00202566
Title Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris
Official title Evaluation of the Anti-anginal Efficacy and Safety of Oral Administration of Ivabradine Compared to Placebo on Top of Background Therapy With Atenolol in Patients With Stable Angina Pectoris. A Four-month Randomised Double-blind, Parallel Group International Multicentre Study.
Acronym ASSOCIATE
Lead sponsor Institut de Recherches Internationales Servier, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Angina Pectoris
Intervention type Drug
Interventions Ivabradine
Enrollment 750
Start date Jun 1, 2005
Completion Oct 1, 2007
First posted Sep 20, 2005
Last update posted Mar 15, 2018
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies